You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

~ Buy the DIMETHYL SULFOXIDE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Dimethyl sulfoxide - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for dimethyl sulfoxide and what is the scope of freedom to operate?

Dimethyl sulfoxide is the generic ingredient in two branded drugs marketed by Mylan Institutional and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for dimethyl sulfoxide. One supplier is listed for this compound.

Summary for dimethyl sulfoxide
US Patents:0
Tradenames:2
Applicants:1
NDAs:2
Drug Master File Entries: 7
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 302
Clinical Trials: 34
Patent Applications: 5,512
What excipients (inactive ingredients) are in dimethyl sulfoxide?dimethyl sulfoxide excipients list
DailyMed Link:dimethyl sulfoxide at DailyMed
Recent Clinical Trials for dimethyl sulfoxide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoPhase 2
Fondazione IRCCS San Gerardo dei TintoriPhase 2
A.O. Ospedale Papa Giovanni XXIIIPhase 2

See all dimethyl sulfoxide clinical trials

Medical Subject Heading (MeSH) Categories for dimethyl sulfoxide

US Patents and Regulatory Information for dimethyl sulfoxide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional RIMSO-50 dimethyl sulfoxide SOLUTION;INTRAVESICAL 017788-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Institutional DIMETHYL SULFOXIDE dimethyl sulfoxide SOLUTION;INTRAVESICAL 076185-001 Nov 29, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.